Scilex Holding Company Provision for Loan, Lease, and Other Losses
Scilex Holding Company (SCLX) reported Provision for Loan, Lease, and Other Losses of $873.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ProvisionForLoanLeaseAndOtherLosses · last filed 2026-08-14
- Scilex Holding Company provision for loan, lease, and other losses for the quarter ending 2026-06-30 was $73.00K.
- Scilex Holding Company provision for loan, lease, and other losses for the quarter ending 2026-03-31 was $800.00K.
- Scilex Holding Company provision for loan, lease, and other losses for the quarter ending 2025-09-30 was $0.00.
- Scilex Holding Company provision for loan, lease, and other losses for the quarter ending 2025-06-30 was $0.00.
| Period end | Provision for Loan, Lease, and Other Losses 3 month | Provision for Loan, Lease, and Other Losses 6 month | Provision for Loan, Lease, and Other Losses 9 month |
|---|---|---|---|
| 2026-06-30 | $73.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $873.00K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $800.00K 10-Q · filed 2026-05-20 | ||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $0.00 derived: sum of 2 quarters · filed 2026-08-14 | $0.00 10-Q · filed 2025-11-14 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $0.00 10-Q · filed 2026-08-14 | |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-20 | ||
| 2024-09-30 | $1.19M 10-Q · filed 2025-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |